Evidence‑based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines.
Loading...
Date
2016-01
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The purpose of the study was to review the current evidence and design a diabetic macular edema (DME)
management guideline specific for India. The published DME guidelines from different organizations
and publications were weighed against the practice trends in India. This included the recently approved
drugs. DME management consisted of control of diabetes and other associated systemic conditions, such as
hypertension and hyperlipidemia, and specific therapy to reduce macular edema. Quantification of macular
edema is precisely made with the optical coherence tomography and treatment options include retinal laser,
intravitreal anti‑vascular endothelial growth factors (VEGF), and implantable dexamethasone. Specific
use of these modalities depends on the presenting vision and extent of macular involvement. Invariable
eyes with center‑involving macular edema benefit from intravitreal anti‑VEGF or dexamethasone implant
therapy, and eyes with macular edema not involving the macula center benefit from retinal laser. The results
are illustrated with adequate case studies and frequently asked questions. This guideline prepared on the
current published evidence is meant as a guideline for the treating physicians.
Description
Keywords
Diabetic macular edema, diabetic retinopathy, evidence, intravitreal injections, laser
Citation
Das Taraprasad, Aurora Ajay, Chhablani Jay, Giridhar Anantharaman, Kumar Atul, Raman Rajiv, Nagpal Manish, Narayanan Raja, Natarajan Sundaram, Ramasamay Kim, Tyagi Mudit, Verma Lalit. Evidence‑based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines. Indian Journal of Ophthalmology. 2016 Jan; 64(1): 14-25.